Patents by Inventor Zhiqiang KU

Zhiqiang KU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF
    Publication number: 20230399384
    Abstract: Provided herein are antibodies binding to Coronavirus S protein and the uses of the antibodies in detecting and treating Coronavirus infection, such as COVID-19.
    Type: Application
    Filed: April 22, 2021
    Publication date: December 14, 2023
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Zhiqiang KU, Ningyan ZHANG, Zhiqiang AN, Xuping XIE, Pei-Yong SHI
  • NOVEL LILRB2 ANTIBODIES AND USES THEREOF
    Publication number: 20230068663
    Abstract: Provided herein are antibodies binding to LILRB2 and the uses of the antibodies in detecting and treating cancer and autoimmune diseases.
    Type: Application
    Filed: January 28, 2021
    Publication date: March 2, 2023
    Applicants: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, IMMUNE-ONC THERAPEUTICS, INC.
    Inventors: Zhiqiang AN, Ningyan ZHANG, Zhiqiang KU, Chengcheng ZHANG, Xiaoye XU, Heyu CHEN, JingJing XIE, Maria Jose COSTA, An SONG, X. Charlene LIAO
  • MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF
    Publication number: 20220267415
    Abstract: This disclosure provides multimeric binding molecules that bind to SARS-CoV-2. This disclosure also provides compositions comprising the multimeric binding molecules, polynucleotides that encode the multimeric binding molecules, and host cells that can produce the binding molecules. Further this disclosure provides methods of using the multimeric binding molecules, including methods for treating and preventing coronavirus disease 2019 (COVID-19).
    Type: Application
    Filed: February 15, 2022
    Publication date: August 25, 2022
    Applicants: The Board of Regents of The University of Texas System, IGM Biosciences, Inc.
    Inventors: Zhiqiang KU, Xuping XIE, Paul HINTON, Ningyan ZHANG, Bruce KEYT, Dean NG, Stephen CARROLL, Pei-Yong SHI, Zhiqiang AN
  • NMES1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210371508
    Abstract: Provided herein are methods for treating cancer, such as breast cancer, by administering an inhibitor of NMES1. Further provided herein are NMES1 monoclonal antibodies which may be used to detect or treat cancer.
    Type: Application
    Filed: May 27, 2021
    Publication date: December 2, 2021
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Ningyan ZHANG, Zhiqiang AN, Zhiqiang KU, Yihong WAN, Jing KRZESZINSKI